Simona Barlera

8.1k total citations · 1 hit paper
77 papers, 3.9k citations indexed

About

Simona Barlera is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Physiology. According to data from OpenAlex, Simona Barlera has authored 77 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Cardiology and Cardiovascular Medicine, 12 papers in Surgery and 7 papers in Physiology. Recurrent topics in Simona Barlera's work include Heart Failure Treatment and Management (21 papers), Cardiovascular Function and Risk Factors (20 papers) and Acute Myocardial Infarction Research (11 papers). Simona Barlera is often cited by papers focused on Heart Failure Treatment and Management (21 papers), Cardiovascular Function and Risk Factors (20 papers) and Acute Myocardial Infarction Research (11 papers). Simona Barlera collaborates with scholars based in Italy, United States and Switzerland. Simona Barlera's co-authors include Roberto Latini, Aldo P. Maggioni, Jay N. Cohn, Serge Masson, Gianni Tognoni, Inder S. Anand, Tarcisio Vago, Lidia Staszewsky, Laura Angelici and Luigi Tavazzi and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

Simona Barlera

73 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Value of Very Low Plasma Concentrations of Troponin T in Patients With Stable Chronic Heart Failure

2007 549 citations Roberto Latini, Serge Masson et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Simona Barlera Italy	31	2.9k	706	502	368	295	77	3.9k
Fabio Magrini Italy	35	2.4k 0.8×	773 1.1×	651 1.3×	249 0.7×	258 0.9×	135	4.0k
Ioannis Paraskevaidis Greece	39	3.0k 1.0×	626 0.9×	486 1.0×	577 1.6×	458 1.6×	185	4.5k
Dong Joo Oh South Korea	30	2.1k 0.7×	1.1k 1.6×	752 1.5×	464 1.3×	311 1.1×	219	3.1k
Tadanori Aizawa Japan	34	2.8k 1.0×	1.1k 1.6×	909 1.8×	507 1.4×	265 0.9×	153	4.0k
Patrick Ohlmann France	30	2.0k 0.7×	885 1.3×	770 1.5×	518 1.4×	488 1.7×	144	3.1k
Christoph Sinning Germany	30	1.8k 0.6×	674 1.0×	400 0.8×	622 1.7×	527 1.8×	137	3.3k
Shuichi Hamasaki Japan	28	2.5k 0.9×	1.0k 1.4×	829 1.7×	410 1.1×	415 1.4×	94	3.8k
Søren Galatius Denmark	26	1.7k 0.6×	519 0.7×	541 1.1×	237 0.6×	576 2.0×	92	2.5k
Seiji Hokimoto Japan	30	1.8k 0.6×	988 1.4×	701 1.4×	431 1.2×	192 0.7×	166	3.1k
Marcello Galvani Italy	27	2.6k 0.9×	843 1.2×	1.2k 2.3×	304 0.8×	289 1.0×	100	3.6k

Countries citing papers authored by Simona Barlera

Since Specialization

Citations

This map shows the geographic impact of Simona Barlera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simona Barlera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simona Barlera more than expected).

Fields of papers citing papers by Simona Barlera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simona Barlera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simona Barlera. The network helps show where Simona Barlera may publish in the future.

Co-authorship network of co-authors of Simona Barlera

This figure shows the co-authorship network connecting the top 25 collaborators of Simona Barlera. A scholar is included among the top collaborators of Simona Barlera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simona Barlera. Simona Barlera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Min, Carolyn M Roos, Runqing Huang, et al.. (2023). Abstract 16898: Myocardial Recovery Associated Gene Cdcp1 Expression Attenuates Cardiac Fibrosis in a Pressure Over-Load Mouse Model. Circulation. 148(Suppl_1).

Ottani, Filippo, Roberto Latini, Lidia Staszewsky, et al.. (2016). Cyclosporine A in Reperfused Myocardial Infarction. Journal of the American College of Cardiology. 67(4). 365–374. 143 indexed citations

Masson, Serge, Simona Barlera, Francesco Colotta, et al.. (2016). A low plasma 1,25(OH) 2 vitamin D/PTH (1–84) ratio predicts worsening of renal function in patients with chronic heart failure. International Journal of Cardiology. 224. 220–225. 14 indexed citations

Rossignol, Patrick, Serge Masson, Simona Barlera, et al.. (2015). Loss in Body Weight is an Independent Prognostic Factor for Mortality in Chronic Heart Failure: Insights from the GISSI-HF and Val-HeFT Trials. European Journal of Heart Failure. 17(4). 424–433. 100 indexed citations

Staszewsky, Lidia, Serge Masson, Simona Barlera, et al.. (2015). Cardiac Remodeling, Circulating Biomarkers and Clinical Events in Patients with a History of Atrial Fibrillation. Data from the GISSI-AF Trial. Cardiovascular Drugs and Therapy. 29(6). 551–561. 9 indexed citations

Rovere, Maria Teresa La, Gian Domenico Pinna, Roberto Maestri, et al.. (2012). Autonomic Markers and Cardiovascular and Arrhythmic Events in Heart Failure Patients: Still a Place in Prognostication? Data from the GISSI-HF Trial. European Journal of Heart Failure. 14(12). 1410–1419. 59 indexed citations

Masson, Serge, Inder S. Anand, Chiara Favero, et al.. (2011). Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart Failure. Circulation. 125(2). 280–288. 168 indexed citations

Disertori, M, Federico Lombardi, Simona Barlera, et al.. (2010). Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico–Atrial Fibrillation (GISSI-AF) trial. American Heart Journal. 159(5). 857–863. 21 indexed citations

Masson, Serge, Aneta Aleksova, Lidia Staszewsky, et al.. (2010). Predicting atrial fibrillation recurrence with circulating inflammatory markers in patients in sinus rhythm at high risk for atrial fibrillation: data from the GISSI atrial fibrillation trial. Heart. 96(23). 1909–1914. 28 indexed citations

10.

Masson, Serge, Roberto Latini, Inder S. Anand, et al.. (2008). Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial). Journal of the American College of Cardiology. 52(12). 997–1003. 253 indexed citations

11.

Abdulla, Jawdat, Simona Barlera, Roberto Latini, et al.. (2006). A Systematic Review: Effect of Angiotensin Converting Enzyme Inhibition on Left Ventricular Volumes and Ejection Fraction in Patients with a Myocardial Infarction and in Patients with Left Ventricular Dysfunction. European Journal of Heart Failure. 9(2). 129–135. 41 indexed citations

12.

Cicoira, Mariantonietta, Aldo P. Maggioni, Roberto Latini, et al.. (2006). Body Mass Index, Prognosis and Mode of Death in Chronic Heart Failure: Results from the Valsartan Heart Failure Trial. European Journal of Heart Failure. 9(4). 397–402. 66 indexed citations

13.

Wong, Maylene, Lidia Staszewsky, Elisa Carretta, et al.. (2005). Signs and Symptoms in Chronic Heart Failure: Relevance of Clinical Trial Results to Point of Care—Data from Val-HeFT. European Journal of Heart Failure. 8(5). 502–508. 9 indexed citations

14.

Alli, C, G Mariottì, Fausto Avanzini, et al.. (2005). Long-term prognostic impact of repeated measurements over 1 year of pulse pressure and systolic blood pressure in the elderly. Journal of Human Hypertension. 19(5). 355–363. 5 indexed citations

15.

Wong, Maylene, Lidia Staszewsky, Roberto Latini, et al.. (2004). Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure. Journal of the American College of Cardiology. 43(11). 2022–2027. 172 indexed citations

16.

Wong, Maylene, Lidia Staszewsky, Roberto Latini, et al.. (2002). Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study. Journal of the American College of Cardiology. 40(5). 970–975. 182 indexed citations

17.

Wong, Maylene, Lidia Staszewsky, Alberto Volpi, et al.. (2002). Quality assessment and quality control of echocardiographic performance in a large multicenter international study: Valsartan in Heart Failure Trial (Val-HeFT). Journal of the American Society of Echocardiography. 15(4). 293–307. 27 indexed citations

18.

Hurst, José, et al.. (1999). Electrocardiographic patterns in acute inferior myocardial infarction with and without right ventricle involvement: Classification, diagnostic and prognostic value, masking effect. Clinical Cardiology. 22(1). 37–44. 22 indexed citations

19.

Imazio, Massimo, Marco Bobbio, Serena Bergerone, Simona Barlera, & Aldo P. Maggioni. (1998). Clinical and epidemiological characteristics of juvenile myocardial infarction in Italy: the GISSI experience.. PubMed. 28(5). 505–12. 55 indexed citations

20.

Latini, Roberto, Gian Luigi Nicolosi, Aldo P. Maggioni, et al.. (1996). The beneficial effect of lisinopril on left ventricular remodelling after a first myocardial infarction is modulated by age. The GISSI-3 echo database. Journal of the American College of Cardiology. 27(2). 281–281. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact